Cornerstone Capital Management Holdings’s Enzo Biochem, Inc. ENZ Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,000	Closed	-$48K	–	1386
2016 Q4	$48K	Buy	+7,000	New	+$44.7K	﹤0.01%	1279
2016 Q3	–	Sell	-45,600	Closed	-$272K	–	1477
2016 Q2	$272K	Buy	45,600 +20,800	+84%	+$115K	﹤0.01%	1147
2016 Q1	$113K	Sell	24,800 -9,500	-28%	-$42.3K	﹤0.01%	1302
2015 Q4	$154K	Sell	34,300 -9,900	-22%	-$41.8K	﹤0.01%	1256
2015 Q3	$140K	Hold	44,200	–	–	﹤0.01%	1281
2015 Q2	$134K	Sell	44,200 -19,600	-31%	-$55.1K	﹤0.01%	1263
2015 Q1	$188K	Sell	63,800 -16,200	-20%	-$53K	﹤0.01%	1192
2014 Q4	$355K	Buy	80,000 +19,800	+33%	+$94.4K	﹤0.01%	1019
2014 Q3	$310K	Buy	60,200 +48,400	+410%	+$258K	﹤0.01%	1043
2014 Q2	$61K	Buy	+11,800	New	+$51K	﹤0.01%	1227

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's ENZ Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of Enzo Biochem, Inc. (ENZ) in Q1 2017, closing a stake of 7,000 shares — an estimated $48K sold.

Cornerstone Capital Management Holdings first reported a position in ENZ in Q2 2014 and held it in 10 quarters. The position peaked at $355K in Q4 2014. 109 funds tracked by Wall St. Rank hold ENZ as of Q1 2017.

Cornerstone Capital Management Holdings reported no remaining Enzo Biochem, Inc. position as of Q1 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 7,000 Enzo Biochem, Inc. shares in Q1 2017, an estimated $48K.
Cornerstone Capital Management Holdings first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 10 quarters.
Cornerstone Capital Management Holdings's Enzo Biochem, Inc. position peaked at $355K in Q4 2014.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.